Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05302479
Other study ID # C.2021.128e
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 15, 2022
Est. completion date September 20, 2023

Study information

Verified date July 2022
Source Brooke Army Medical Center
Contact Matt H Hammerle, DPT
Phone 210-916-8693
Email matt.h.hammerle.civ@mail.mil
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Eligible participants will complete the COMPASS 31 (year), modified COMPASS 31(one month) and the NSI (one month) questionnaires at baseline and complete the modified COMPASS 31 and the NSI after usual care of treatment. The investigators will 1. Compare results for the COMPASS 31(year) to the modified COMPASS 31(month) at baseline. 2. Compare modified COMPASS 31(month) to the NSI at baseline and post intervention.


Description:

The Composite Autonomic Symptom Score (COMPASS 31) is a validated questionnaire designed to measure self reported autonomic symptoms in the last year in individuals with migraine and post-concussive symptoms. In order to use this questionnaire to measure response to treatment it would be preferable to determine if the results of the COMPASS 31 are similar if the patient is asked to complete this thinking about symptoms in the last year as per the usual questionnaire, compared to a modified COMPASS 31 where symptoms in the past month will be assessed. This prospective trial will compare results of the COMPASS 31 (year) to the modified COMPASS 31 (month). Since the present gold standard for outcome measures in post-concussive treatment is the neurobehavioral symptom inventory (NSI), this study will also compare results of the modified COMPASS 31(month) to the NSI outcome measure at baseline and post treatment to validate the utilization of the modified version of the COMPASS 31(month) for use in the post-concussive population as an outcome measure for self-reported autonomic nervous system symptoms.


Recruitment information / eligibility

Status Recruiting
Enrollment 35
Est. completion date September 20, 2023
Est. primary completion date September 20, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Patients who present to the BAMC_BIRS clinic for treatment of headache between the ages of 18-64. Exclusion Criteria: - Normal composite autonomic symptom score.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
COMPASS 31 questionnaire
A 31 question questionnaire that measures autonomic symptoms.

Locations

Country Name City State
United States Brooke Army Medical Centre Houston Texas

Sponsors (3)

Lead Sponsor Collaborator
Brooke Army Medical Center The Defense and Veterans Brain Injury Center, The University of Queensland

Country where clinical trial is conducted

United States, 

References & Publications (2)

Howard L, Dumkrieger G, Chong CD, Ross K, Berisha V, Schwedt TJ. Symptoms of Autonomic Dysfunction Among Those With Persistent Posttraumatic Headache Attributed to Mild Traumatic Brain Injury: A Comparison to Migraine and Healthy Controls. Headache. 2018 Oct;58(9):1397-1407. doi: 10.1111/head.13396. Epub 2018 Aug 29. — View Citation

King PR, Donnelly KT, Donnelly JP, Dunnam M, Warner G, Kittleson CJ, Bradshaw CB, Alt M, Meier ST. Psychometric study of the Neurobehavioral Symptom Inventory. J Rehabil Res Dev. 2012;49(6):879-88. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Composite Autonomic Symptom Score questionnaire (Compass 31)-Self reported autonomic nervous system symptoms in the past year. Self reported autonomic nervous system symptoms in the past year will be measured using the validated, refined and abbreviated Composite Autonomic Symptom Score questionnaire (Compass 31). Scoring ranges from 0-100 with higher scores indicating more autonomic symptoms. One year
Primary Composite Autonomic Symptom Score questionnaire (Compass 31)- Self reported autonomic nervous system symptoms in the past month (COMPASS 31-month). Self reported autonomic nervous system symptoms in the past month will be measured using the validated, refined and abbreviated Composite Autonomic Symptom Score questionnaire (Compass 31-month). Scoring ranges from 0-100 with higher scores indicating more autonomic symptoms. One month
Primary Neurobehavioural symptom inventory (NSI) a 22-item self-report questionnaire of neurobehavioral symptoms. Neurobehavioural symptom inventory (NSI) a 22-item self-report questionnaire of neurobehavioral symptoms. Scores range from 0-88 with higher scores indicating more symptoms. One month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05545423 - Effect of Instrument-Assisted Soft Tissue Mobilization on Proprioception and Disability in Patients With Cervicogenic Headache N/A
Not yet recruiting NCT05289414 - Radiofrquency Targeting Mid Cervical Medial Branches vs GON in Cervicogenic Headache Phase 2/Phase 3
Completed NCT01687881 - Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache N/A
Recruiting NCT05617365 - Treating Chronic Cervicogenic Head and Neck Pain Phase 1/Phase 2
Recruiting NCT05491915 - The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain N/A
Active, not recruiting NCT02908984 - Specific Neck Rehabilitation for Unilateral Headache and Neck Pain, and Structural and Functional Changes in the Brain N/A
Completed NCT01790074 - Trigger Point Therapy in Cervicogenic Headache N/A
Terminated NCT03730896 - Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches N/A
Completed NCT05582616 - The Safety and Feasibility of tDCS Combined With Conservative Treatment for Cervicogenic Headaches N/A
Recruiting NCT06459726 - Effects of Shi Style Cervical Mobilization Versus SNAGS in Patients With Cervicogenic Headache N/A
Completed NCT04521218 - Thrust Joint Manipulation and Reverse SNAGS (Sustained Natural Apophyseal Glides) in Cervicogenic Headache N/A
Completed NCT00184197 - Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache Phase 2
Completed NCT04625387 - Dry Needle In Management of Cervicogenic Headache N/A
Completed NCT05865808 - Effects of Sustained Natural Appophyseal Glide Versus Rocababo 6x6 Program in Subjects With Cervicogenic Headache. N/A
Completed NCT05827185 - Effects of Workstation Ergonomics and Physiotherapy in Cervicogenic Headache. Phase 2
Completed NCT03919630 - Mobilization Versus Manipulation for the Treatment of Cervicogenic Headaches N/A
Completed NCT04454541 - Efficacy of Ultrasound-Guided Multifidus Cervicis Plan Block Vs Greater Occipital Nerve Block for Cervicogenic Headache N/A
Completed NCT04242290 - Cervicospinal Posture and Pain in Cervicogenic Headache
Completed NCT05754931 - Deep Neck Flexors Training Versus Muscle Energy Technique on Cervicogenic Headache N/A
Completed NCT05849545 - Effects of Garston Tool and Neuromuscular Reeducation in Cervical Headache N/A